3.0
21 June 2019
Current employee
Recommend
CEO approval
Business outlook
Pros
Generous base, direct management top notch, man at the top has desire move the company in the right direction.
Cons
Despite the best efforts of the CEO, it is incredibly difficult to turn around a company the size of Novartis with an extremely top down, big Pharma approach. The desire exists to move towards a more bio technology culture, however even with in bio technology much of the behavior mirrors primary care big Pharma.